Artificial intelligence (AI) and machine learning (ML) continue to drive innovation across biotech and healthcare. Novel AI-powered platforms enhance drug discovery for spinal cord injury and autoimmune disorders, while ML models improve cancer risk prediction and diagnostic imaging. Recent studies illustrate AI’s use in optimizing programmable protein production, biomanufacturing regulation adaptation, and detection of physician fatigue from clinical notes. This growing AI integration is propelling precision medicine, streamlining bioprocessing, and redefining diagnostics.